STC-1020

N/A

Report date: 2025/01/26 18:07:04

Base Information

Drug NameSTC-1020
Drug Alias Nameallogenic tumor cell-based immunotherapy (Brenus Pharma)STC-1020
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrenus Pharma SAS
China Registration ClassN/A

Develop Information

Active CompaniesBrenus Pharma SAS
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A